Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

Part of paid clinical trials in Brooklyn, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT05164744
Status
Recruiting
Apply to this trial

Conditions

  • COVID-19
  • COVID-19 Acute Bronchitis
  • COVID-19 Acute Respiratory Distress Syndrome
  • COVID-19 Lower Respiratory Infection
  • COVID-19 Pneumonia
  • COVID-19 Respiratory Infection
  • Coronavirus Disease 2019

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Cardiac MRI — DIAGNOSTIC_TEST
    Patients participate in an NIH funded cardiac MRI to assess their symptoms.
  • Echocardiogram — DIAGNOSTIC_TEST
    Patients participate in an NIH funded cardiac echocardiogram to assess their symptoms.
  • 6-minute walk test — DIAGNOSTIC_TEST
    Patients participate in a 6-minute walk test to assess their symptoms.
  • Questionnaire — DIAGNOSTIC_TEST
    Patients answer a survey-based questionnaire to assess their symptoms.

Study Details

The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed therapies accordingly.

Key Dates

Start date
Jul 1, 2021
Status verified
Jan 2026
Primary completion
Jul 30, 2026
Completion
Jul 30, 2026

Study Design

Enrollment
510 participants (estimated)

Arms

  • Arm: Diagnosed with COVID-19
    Participants in the study cohort will have been diagnosed with COVID-19 by a PCR (polymerase chain reaction) positive test

Primary Outcome Measure

Participants with focal fibrosis based on cardiac imaging (MRI and echocardiogram) > 3 months post-COVID-19 (coronavirus disease 2019) diagnosis, at first study visit [ Time Frame: Day of first study visit, > 3 months post acute COVID-19 infection ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
New York Presbyterian-Brooklyn Methodist HospitalBrooklynNew York11215-3609
Marline Attallah, MD
[email protected]
2127462627
Elizabeth Manowitz, BS
[email protected]
2127462627
Jiwon Kim, MD (PRINCIPAL_INVESTIGATOR)
Jonathan W Weinsaft, MD (SUB_INVESTIGATOR)
New York Presbyterian QueensNew YorkNew York10021
Susan Ingenito
[email protected]
7186702414
Elizabeth Manowitz, BS
[email protected]
2127462627
Jiwon Kim, MD (PRINCIPAL_INVESTIGATOR)
Jonathan W Weinsaft, MD (SUB_INVESTIGATOR)
Weill Cornell Medicine/New-York Presbyterian HospitalNew YorkNew York10021
Elizabeth Manowitz, BS
[email protected]
2127462627
Mahniz Reza, BA
[email protected]
2127462627
Jiwon Kim, MD (PRINCIPAL_INVESTIGATOR)
Jonathan W Weinsaft, MD (SUB_INVESTIGATOR)

Find similar trials in Brooklyn, NY

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
New York Presbyterian-Brooklyn Methodist Hospital· Brooklyn, NYNew York Presbyterian Queens· New York, NYWeill Cornell Medicine/New-York Presbyterian Hospital· New York, NY

Related Studies